Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Molecular Pathway Controls Metastasis in Mouse Melanoma Model

By LabMedica International staff writers
Posted on 05 Jan 2015
Cancer researchers have found that the protein Chi3l1 (Chitinase 3-like-1) stimulates formation of metastases in a mouse model under the regulatory influence of the protein semaphorin 7a (Sema7a) and its receptors.

The CHI3L1 gene encodes a glycoprotein member of the glycosyl hydrolase 18 family. More...
The protein product lacks chitinase activity and is secreted by activated macrophages, chondrocytes, neutrophils, and synovial cells. The protein is thought to play a role in the process of inflammation and tissue remodeling. Semaphorins are a class of secreted and membrane proteins that act as axonal growth cone guidance molecules. They primarily act as short-range inhibitory signals and signal through multimeric receptor complexes with plexins being the major class of semaphorin receptor proteins.

Chi3l1 was found in earlier studies to be induced in cancers where it indicated a poor prognosis. However, it has not been known whether it actually contributed to cancer progression. To address this gap in knowledge investigators at Brown University (Providence, RI, USA) examined the production of Chi3l1 in a mouse model of melanoma lung metastases.

They reported in the December 15, 2014, online edition of the journal Cancer Research that Chi3l1 levels were elevated in mice, as in humans, with progressing cancer. Chi3l1 was induced during pulmonary melanoma metastasis, and this induction was regulated by Sema7a, interacting in stimulatory or inhibitory ways with its beta-1 integrin or Plexin C1 receptors, respectively. In mouse strains with genetic deletions of CHI3L1 or Sema7a, there was a significant reduction in pulmonary metastasis. Furthermore, antiserum raised against Chi3l1 or Sema7a induced the same reduction in metastasis as was produced by genetic deletions. Melanoma lung metastasis was also decreased in the absence of the cytokine IL-13Ralpha2, a recently identified receptor for Chi3l1, consistent with a key role for Chi3l1 in melanoma spread.

"We think everybody has Chitinase 3-like-1 (Chi3l1) in them because it plays a major role in our ability to fight off infections," said senior author Dr. Jack A. Elias, professor of medicine and biological sciences at Brown University. "But one of the things this paper shows is that inducing this molecule seems to be very important in the ability of tumors to spread. That leads us to believe this may be a fundamental pathway in the generation of metastases. We know what molecules are involved in the triggering of this. We do not know where they are and which of them are on the tumor and which are in the normal tissue around the tumor."

Related Links:

Brown University



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.